α2A-Adrenergic regulation of cyclic AMP accumulation and lipolysis in human omental and subcutaneous adipocytes

International Journal of Obesity

Volumn 20, Issue 2, 1996, Pages 185-189

  Vikman, H L ^a   Savola, J M ^b   Raasmaja, A ^a   Ohisalo, J J ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Biochem Pharmacol Lab   (Finland)

^c Department of Medical Chemistry ^*  (Finland)

Author keywords

3H RX821002; Dexmedetomidine; Intraabdominal fat; Metabolic syndrome; MPV 1743AIII; UK14304

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; BRIMONIDINE; CELL SURFACE RECEPTOR; CYCLIC AMP; DEXMEDETOMIDINE; GLYCEROL; ISOPRENALINE;

ADIPOCYTE; ADULT; AGED; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LIPOLYSIS; MALE; OMENTUM; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; SUBCUTANEOUS FAT;

ABDOMEN; ADIPOCYTES; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; CYCLIC AMP; EPINEPHRINE; FEMALE; GLYCEROL; HUMANS; IMIDAZOLES; ISOPROTERENOL; LIPOLYSIS; MALE; MEDETOMIDINE; MIDDLE AGED; OMENTUM; QUINOXALINES; RECEPTORS, ADRENERGIC, ALPHA;

EID: 0030071648     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Frayn K, Coppack S. Insulin resistance, adipose tissue and coronary heart disease. Clin Sci 1992; 82: 1-8.
2. Björntorp P. Obesity and the risk of cardiovascular disease. Ann Clin Res 1985; 17: 3-10.
3. Park KS, Rhee BD, Lee K-U, Kim SY, Lee HK, Koh C-S, Min HK. Intraabdominal fat is associated with decreased insulin sensitivity in healthy young men. Metab Clin Exp 1991; 40: 600-603.
4. Svedberg J, Björntorp P, Smith U. Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 1990; 39: 570-574.
5. Bolinder J, Kager L, Ostman J, Arner P. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 1983; 32: 117-123.
6. Mauriege P, Galitzky J, Berlan M, Lafontan M. Heterogenous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences. Eur J Clin Invest 1987; 17: 156-165.
7. 2. Metab Clin Exp 1991; 40: 990-996.
8. Vikman H-L, Ranta S, Kiviluoto T, Ohisalo JJ. Different metabolic regulation by adenosine in omental and subcutaneous adipose tissue. Acta Physiol Scand 1991; 142: 405-410.
9. Fried SK, Leibel RL, Edens NK, Kral JG. Lipolysis in intraabdominal adipose tissues of obese women and men. Obesity Res 1993; 1: 443-448.
10. Lafontan M, Berlan M, Galitzky J, Montastuc JL. Alpha-2 adrenoceptors in lipolysis: α2-antagonists and lipid-mobilizing strategies. Am J Clin Nutr 1992; 55: 219-227.
11. Lafontan M, Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 1993; 34: 1057-1091.
12. Yeaman SJ. Hormone-sensitive lipase - a multipurpose enzyme in lipid metabolism. Biochim Biophys Acta 1990; 1052: 128-132.
13. Vikman H-L, Ohisalo JJ. Regulation of adenylate cyclase in plasma membranes of human intraabdominal and abdominal subcutaneous adipocytes. Metab Clin Exp 1993; 40: 739-742.
14. Hellmer J, Marcus C, Sonnenfeld T, Arner P. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. J Clin Endocrinol Metab 1992; 75: 15-20.
15. Rodbell M. Metabolism of isolated fat cells. J Biol Chem 1964; 239: 375-380.
16. Kather H, Wieland E. Luminometric method. In: Bergmeyer HU (ed). Methods of Enzymatic Analysis VI. Verlag Chemie: Weinheim, 1984, pp 510-518.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt Biochem 1976; 72: 248-254.
18. Brown MB, Engleman L, Jennrich RI. In: Dixon WJ (chief ed). BMDP statistical software manual 2. University of California Press: Berkeley, 1990, pp 1207-1244.
19. Landaw E, Sampson P, Toporec J. Advanced nonlinear regression in BMDP: comparison to ad hoc dummy data procedures. Proc Stat Comp Sect Am Stat Ass 1982; 1: 228-233.
20. Savola J-M, Ruskoaho J, Puurunen J, Salonen JS, Kärki NT. Evidence for medetomidine as a selective and potent agonist at α2-adrenorecetors. J Auton Pharmacol 1986; 5: 275-284.
21. Doze VA, Chen BX, Maze M. Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors. Anesthesiology 1989; 71: 75-79.
22. Bylund DB. Subtypes of α1- and α2-adrenergic receptors. FASEB J 1992; 6: 832-839.
23. Ostman J, Arner P, Engfeldt P, Kager L. Regional differences in the control of lipolysis in human adipose tissue. Metabolism 1979; 28: 1198-1205.
24. Vikman H-L, Hreniuk SP, Kauffman GF, LaNoue KF, Martin LF, Ohisalo JJ. Cyclic AMP and glycerol concentrations in freeze-clamped human omental and subcutaneous adipose tissues. Int J Obesity 1995; 19: 388-391.
25. Mauriège P, Després JP, Prud'homme D, Pouliot MC, Marcotte M, Tremblay A, Bouchard C. Regional variation in adipose tissue lipolysis in lean and obese men. J Lipid Res 1991; 32: 1625-1633.
26. 3H-RX821002. J Pharmacol Exp Ther 1990; 252: 312-319.